Vendor, New York, NY
Ceramedix Holding, LLC
UEI JLZSJRJVKJ49, CAGE 7SUF5
2 awards and $1,500,000 obligated between June 24, 2026 and July 20, 2026, 100% under full and open competition, against 17.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $1,500,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93026C00007Definitive Contract, June 24, 2026, Full and Open Competition, 18 offers | National Institutes of Health NiaidNational Institutes of Health | Development of Radiation/Nuclear Medical Countermeasures (Mcms) and Biodosimetry Devices. 7-1/2026 to 6/30/2026. Dap-Ncap-00000073.NAICS 541714, PSC AN12 | $1,500,000 |
| 75N93023C00015Definitive Contract, July 20, 2026, Full and Open Competition, 16 offers | National Institutes of Health NiaidNational Institutes of Health | Eo 14398NAICS 541714, PSC AN12 | $0 |
- Places of performance
- New York
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 2 awards